Found 2140 clinical trials
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.
- 303 views
- 08 Nov, 2020
- 1 location
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven PhaseIII study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease insubjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
progression of kidney disease insubjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
- 177 views
- 23 Nov, 2020
- 1 location
If you are at least 18 years of age, have been diagnosed and currently treating for type 2 diabetes, please contact Coastal Carolina Research Center about our new medical research study.
If you are at least 18 years of age, have been diagnosed and currently treating for type 2 diabetes, please contact Coastal Carolina Research Center about our new medical research study.
- 193 views
- 25 Mar, 2021
- 1 location
A long-term 4+ year, double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events
A long-term 4+ year, double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse
- 342 views
- 08 Nov, 2020
- 1 location
Study to assess the genetic factors predisposing individuals and families to develop obesity/diabetes
Study to assess the genetic factors predisposing individuals and families to develop obesity/diabetes
- 4117 views
- 08 Nov, 2020
- 1 location
Pemafibrate (K-877) to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes.
Pemafibrate (K-877) to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes.
- 290 views
- 25 Mar, 2021
- 1 location
BAY-94-8862/16244 - A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
- 1061 views
- 25 Mar, 2021
- 1 location
If you are living with OVERWEIGHT or OBESITY, then the REDEFINE 2 study may be for you
If you are living with overweight or obesity, then the REDEFINE 2 study may be for you. This study investigates the effect of an investigational medicine on weight loss.
- 55 views
- 03 Feb, 2023
- 1 location
Weekly Basal Insulin - Allowing More Flexibility With Treating Type 1 Diabetes. (In the Greater Seattle Area.)
We are currently seeking volunteers who are diagnosed with Type 1 Diabetes and who are treating with multiple daily injections (basal and bolus insulin regimens) for the past 1 year.
- 36 views
- 08 Oct, 2021
- 1 location
Do you have heart disease or diabetes? Lowering cholesterol lowers risk of heart attack or stroke.
Do you have heart disease or diabetes? Lowering cholesterol lowers risk of heart attack or stroke.
- 337 views
- 08 Nov, 2020
- 2 locations